Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Science communication sits at the center of this dementia and brain health question.
The National Academies of Sciences, Engineering, and Medicine, in partnership with Schmidt Sciences, has recognized outstanding excellence in science communication through the 2025 Eric and Wendy Schmidt Awards. Among the 24 winners announced across eight categories receiving a combined $640,000, the award program spotlighted exceptional work in making complex scientific research accessible to general audiences. For the dementia research and care community, this recognition carries particular significance: journalist Calli McMurray received an award for her article “How Inbreeding Almost Tanked an Up-and-Coming Model of Alzheimer’s Disease,” published in The Transmitter, demonstrating how rigorous science journalism can illuminate critical challenges in Alzheimer’s research methodology and advance public understanding of the disease.
These awards represent more than just recognition of individual achievement. They highlight a growing recognition that how we communicate about science—particularly neurodegenerative diseases like Alzheimer’s—directly affects public trust, research funding, and the quality of information patients and families receive. McMurray’s award-winning piece exemplifies this importance by addressing a technical but crucial problem in Alzheimer’s research: the genetic bottlenecks affecting animal models that scientists rely on to understand the disease. By translating this complex issue into clear, engaging narrative, her work made visible the often-hidden limitations of research methods that affect the credibility and applicability of Alzheimer’s findings.
Table of Contents
- How Do Science Communication Awards Recognize Excellence in Alzheimer’s Journalism?
- The Critical Role of Transparent Science Communication in Dementia Research
- How Major Institutions Are Elevating Standards for Health and Science Communication
- Comparing Professional Science Journalism to Self-Promotion in Alzheimer’s Reporting
- The Limited Voice of Science Journalism in Dementia and Aging Coverage
- What Makes Award-Winning Alzheimer’s Reporting Stand Out
- The Future of Science Communication in Aging and Neurodegeneration Research
- Conclusion
How Do Science Communication Awards Recognize Excellence in Alzheimer’s Journalism?
The Schmidt Awards operate across three distinct categories of communicators: research scientists, science journalists, and science communicators. Each category includes one top prize worth $40,000 and two additional awards of $20,000 each, reflecting the program’s commitment to supporting excellence across different pathways of scientific communication. For journalists specifically, this recognition validates the essential work of translating laboratory findings into narratives that inform public discourse about health and disease. McMurray’s recognition for her Alzheimer’s piece demonstrates how awards in this category specifically honor journalism that doesn’t simply report findings but helps readers understand the underlying scientific logic, methodology concerns, and real-world implications of research.
The value of such recognition extends beyond the monetary reward. When prestigious institutions like the National Academies publicly acknowledge outstanding science communication about Alzheimer’s, they establish standards for what rigorous, honest reporting looks like. McMurray’s article didn’t sensationalize a problem; instead, it explained a genuine scientific challenge—that the genetic homogeneity of widely-used mouse models of Alzheimer’s disease created limitations for translating findings to human populations—in ways that respected both the science and the reader’s intelligence. This approach stands in contrast to much health journalism that either oversimplifies to the point of inaccuracy or remains inaccessible to non-specialists.
The Critical Role of Transparent Science Communication in Dementia Research
One significant limitation of mainstream health coverage is its tendency toward what researchers call “promise bias”—the overemphasis of potential breakthroughs while downplaying limitations, failed approaches, or methodological concerns. This pattern has particular consequences in Alzheimer’s reporting, where patients and families living with the disease are often desperate for hope and may seek unproven treatments based on overhyped research announcements. When journalists like McMurray take time to explain what went wrong or what remains unsolved in research—such as the inbreeding problems in Alzheimer’s animal models—they provide an essential counterbalance. They help audiences understand that scientific progress is iterative, that problems are being identified and addressed, and that honest reporting about limitations is a sign of integrity, not failure.
The challenge that McMurray’s award-winning work addresses illustrates why this transparency matters practically. Animal models are foundational to Alzheimer’s research; they allow scientists to test hypotheses and therapeutic approaches that would be impossible to study directly in human subjects. However, many Alzheimer’s models, particularly transgenic mice expressing human Alzheimer’s-associated genes, have been bred in genetically restricted ways for decades. This inbreeding can introduce genetic variations that confound results, making it harder to distinguish whether observed effects come from the disease model itself or from unintended genetic artifacts. By reporting this technical problem, McMurray’s article helped readers understand that when a promising drug fails in human trials after succeeding in animal studies, the explanation might involve methodological factors like these—making the research system more trustworthy by being honest about its mechanisms and limitations.
How Major Institutions Are Elevating Standards for Health and Science Communication
The decision by the National Academies and Schmidt Sciences to explicitly reward excellence in science communication reflects a shifting recognition among research institutions that how findings are communicated is itself a form of scientific rigor. The program distributes $640,000 across 24 winners working in various roles: some are active research scientists who communicate their own work, others are professional science journalists, and others work in dedicated science communication roles. This structure acknowledges that excellence in communication takes different forms and comes from different professional backgrounds. For Alzheimer’s and dementia coverage specifically, this multi-category approach matters because different communicators reach different audiences.
A research scientist explaining Alzheimer’s mechanisms to colleagues might use technical language appropriate to that audience. A science journalist writing for a general publication must make those same mechanisms clear to readers without scientific training. A science communicator working for a nonprofit organization might focus on what findings mean for patients and caregivers. The Schmidt Awards recognize that all of these roles require excellence, and that a single researcher’s ability to explain her own work brilliantly doesn’t automatically make her a good science journalist—and vice versa.
Comparing Professional Science Journalism to Self-Promotion in Alzheimer’s Reporting
A practical distinction worth understanding is the difference between journalism and promotion, particularly as media landscapes shift. In an era where research institutions increasingly manage their own communications through social media, press releases, and direct messaging to journalists, there’s real value in independent science journalism that investigates research claims from the outside. When a researcher or institution announces a breakthrough, an independent journalist’s job includes asking critical questions: What exactly did the study show? What were the limitations? Who funded this research? What alternative explanations exist? McMurray’s award-winning article embodied this investigative approach by diving into a specific methodological problem in Alzheimer’s research that affects how we should interpret findings from major research programs.
She didn’t attack the researchers or the importance of their work; instead, she reported a real scientific problem that needs solving. This tradeoff—taking time to report complexity rather than simply amplifying announcements—makes for better-informed readers but can be harder to fund and harder to publish quickly. Institutions increasingly focused on rapid communication cycles and engagement metrics may not prioritize the kind of sustained investigation that McMurray’s piece required. That’s why programs like the Schmidt Awards matter: they create market signals that this work has value.
The Limited Voice of Science Journalism in Dementia and Aging Coverage
One warning worth noting is that despite the importance of science journalism, the number of professional science journalists has declined significantly in recent decades, particularly in regional media. A single award to someone like McMurray, even a well-deserved recognition, can’t offset the broader erosion of newsroom capacity for science reporting. This matters for Alzheimer’s and dementia coverage because these are complex fields where good reporting requires time and expertise. A journalist covering Alzheimer’s needs to understand neurobiology, understand research methodology, understand the clinical landscape, and understand the patient and caregiver experience—a combination of knowledge that typically requires either specialist training or substantial time investment.
Additionally, there’s a limitation in how much award recognition can do to change incentive structures in publishing. An award validates excellence, but publications make editorial decisions based on circulation, engagement, and advertising revenue. A 3,000-word dive into methodological problems in Alzheimer’s mouse models might be excellent journalism, but it may not drive the kind of clicks or subscriptions that shorter, more sensational coverage generates. The existence of the Schmidt Awards and winners like McMurray proves that excellent science communication about Alzheimer’s exists and is valued by institutions—but it doesn’t necessarily solve the fundamental tension between what makes good journalism and what makes profitable media.
What Makes Award-Winning Alzheimer’s Reporting Stand Out
McMurray’s piece exemplifies several elements that distinguish outstanding Alzheimer’s reporting. First, it identified a specific, researchable problem—the genetic bottlenecks in Alzheimer’s mouse models—rather than writing a generic story about “progress in Alzheimer’s research.” Second, it engaged directly with researchers working on the problem, allowing readers to understand their perspectives and constraints. Third, it explained why the problem matters: if the mouse models don’t accurately reflect human Alzheimer’s biology, the drugs that work in mice might not work in people, or they might fail for reasons unrelated to the disease itself. This chain of reasoning helps readers understand cause and effect in how research translates to human benefit or failure.
The other dimension that likely contributed to recognition was McMurray’s respectful approach to complexity. She didn’t frame researchers as villains for using these models or as foolish for not noticing these problems sooner. Instead, she explained the history and constraints that led to the current situation, allowing readers to understand how well-intentioned scientists working within existing systems and resources sometimes create problems that later researchers must solve. This approach respects both the science and the reader—it doesn’t pretend to simplicity where complexity exists, but it makes that complexity navigable.
The Future of Science Communication in Aging and Neurodegeneration Research
As Alzheimer’s disease remains a major public health challenge affecting millions of people and their families, the quality and integrity of science communication about the disease will likely become increasingly important. New research areas—immunotherapy approaches, tau protein targeting, early detection through blood biomarkers—present opportunities for both excellent reporting and for overhyped coverage that might drive patients toward unproven treatments or toward despair when early-stage findings don’t quickly translate to clinical benefit.
The recognition programs like the Schmidt Awards signal that research institutions and funders are committed to supporting the infrastructure of good science communication. For readers and patients seeking trustworthy information about Alzheimer’s, the existence of award-winning journalism like McMurray’s piece provides a benchmark: this is what rigorous, honest science reporting about the disease looks like. It’s worth seeking out and supporting publications that maintain the standards exemplified by award winners, particularly as the broader media landscape continues to shift.
Conclusion
The 2025 Eric and Wendy Schmidt Awards for Excellence in Science Communications recognized 24 outstanding communicators across research, journalism, and dedicated science communication roles. Among them, journalist Calli McMurray received recognition for reporting on a critical but underreported challenge in Alzheimer’s research methodology—the genetic bottlenecks affecting widely-used mouse models. Her work exemplifies what award-winning science journalism looks like: technically rigorous, respectfully reported, and genuinely illuminating for readers trying to understand the disease and the research landscape around it.
For individuals and families affected by Alzheimer’s, the presence of strong science communication represented by award-winning journalists like McMurray provides a foundation for informed decision-making. As new Alzheimer’s treatments and approaches continue to emerge, the ability to read honest, complex reporting about their basis, limitations, and potential becomes increasingly valuable. Supporting quality science journalism and recognizing excellence in science communication isn’t a luxury—it’s an essential part of building and maintaining public trust in the research enterprise and ensuring that people have access to accurate information about their health.
You Might Also Like
- Occupational Therapy Programs Maintain Functional Skills in Alzheimer’s
- Large Language Models Applied to Alzheimer’s Literature Analysis
- Dance and Movement Therapy Shows Promise for Alzheimer’s Patients
For more, see National Institute on Aging.
